Background: The aim of this study was to explore the effect of Tongxinluo on myocardial fibrosis in diabetic rats and its possible mechanism of action. Methods: Diabetic rat models were established and then divided into three groups: control, diabetes, and Tongxinluo groups. Heart function and myocardial interstitial collagen volume fraction were investigated, and the protein and mRNA expression levels of transforming growth factor beta 1 (TGF-b 1 ), Smad 3 , and Smad 7 were measured. Results: Heart function was clearly abnormal in the diabetes group compared with that in the control group, and the collagen volume fraction and mRNA expression levels of TGF-b 1 and Smad 3 were higher. However, the protein and mRNA expression levels of Smad 7 were lower. In the Tongxinluo group, it was observed that these indicators were improved. Conclusion: Tongxinluo was effective for the prevention and treatment of myocardial fibrosis in diabetic rats. It probably mediates the expressions of TGF-b 1 , Smad 3 , and Smad 7 in rat cardiomyocytes to reduce the occurrence of myocardial fibrosis in diabetic rats.
Introduction
In 1972, Rubler 1 first proposed diabetic cardiomyopathy (DCM) as one of the microangiopathies in diabetes with a very complicated pathogenesis, independent of the occurrence of hypertension and coronary artery disease. The prevailing opinion now is that DCM is highly associated with the renineangiotensinealdosterone system, oxidative stress, inflammatory factors, growth factors, and extracellular matrix (ECM), which play an essential role in the development and occurrence of DCM.
2e6 Furthermore, the major pathological changes of DCM are an increase in the size of myocardial microvascular walls, a narrow lumen, ECM accumulation, and myocardial fibrosis, 7 which is a characteristic pathological change in DCM. 8 Recent studies showed that a change in the expression of transforming growth factor beta 1 (TGF-b 1 ) and an abnormal ECM might be involved in the development and occurrence of DCM. 9, 10 TGF-b 1 is the most powerful cytokine that has been recognized to induce fibrosis. It performs many cellular functions, including the control of fibroblast proliferation, differentiation, migration, and production of ECM. TGF-b 1 also increases protein expression in the ECM of different cell types; however, overexpression of TGF-b 1 promotes myocardial fibrosis and hypertrophy leading to ventricular remodeling. 11 The Smad protein is found in the cytoplasm; it is the downstream signal transduction molecule Conflicts of interest: The authors declare that they have no conflicts of interest related to the subject matter or materials discussed in this article.
of the TGF-b1 family of receptors as well as the key regulatory factor of the TGF-b 1 /Smad signal transduction pathway. Moreover, the TGF-b 1 /Smad signaling pathway in myocardial tissue is closely associated with DCM.
Tongxinluo, in capsule form, is a traditional Chinese medicine. It is a compound preparation consisting of many kinds of herbs and insects, developed using the traditional Chinese collateral disease theory. Tongxinluo is crushed and squeezed, which helps release the active ingredients into solution and improves bioavailability and efficacy. Some reports have indicated that Tongxinluo has a good clinical efficacy when used to treat patients with angina. This study explored the effect of Tongxinluo on the prevention and treatment of myocardial fibrosis in rats with diabetes induced by streptozotocin (STZ) and the possible mechanism of action of Tongxinluo, and examined the expression levels of TGF-b 1 , Smad 3 , and Smad 7 in myocardial tissue.
Methods

Animals
Healthy Sprague-Dawley male rats ranging in age from 7 weeks to 8 weeks and weighing 180e220 g were provided by the Experimental Animal Center of Liaoning Medical College. The certification number was SYXK (Liao) 2005-0013. This study was conducted in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The animal use protocol was reviewed and approved by the Institutional Animal Care and Use Committee of Shandong University.
Establishment of diabetic model and groups
Thirty healthy Sprague-Dawley male rats that were deprived of food and water for 12 hours were injected with 1% STZ solution (Sigma, 22 chaowai street, fanli mansion, 4 floor, room 407, Chaoyang, Beijing) through the caudal vein. An STZ (1%) solution was prepared with 0.5 mol/L of sodium citrate buffer (pH 4.5). As controls, 10 rats were injected with the same dose (0.5 mol/L) of the sodium citrate buffer. After 72 hours, blood samples were collected to measure blood glucose level using a blood glucose monitor (SureStep Plus; Johnson Company). If the blood glucose concentration exceeded 16.7 mmol/L for 3 consecutive days, a diabetic model was assumed to have been successfully established. Thereafter, 28 diabetic rats were successfully established, which were then randomly divided into a diabetic group and a Tongxinluo group; each group had 14 rats. In the Tongxinluo group, 1.0 g Tongxinluo ultrafine powder (equivalent to 1.43 g of crude drug; lot number: 070406; HebeiYiling Pharmaceutical Institute, Shijiazhuang, China), consisting of ginseng, leech, scorpion, chilopod, woodlouse, red paeonia, cicada, and borneol, was dissolved in physiological saline and intragastrically administered to rats at a dose of 0.5 g/kg once a day. The same volume of water was administered to the control and diabetic groups for 12 weeks. The rats were weighed and blood samples were collected to determine blood glucose level once a week. In addition, drug dose was regulated according to weight.
Measurement of heart function
At the end of 12 weeks, rats from the three groups were anesthetized by injecting them with a 20% urethane solution (5 mL/kg). Tracheal cannulation was performed on the rats; one end of the tube was inserted into the left ventricular chamber and the other end was connected to a pressure transducer to record left ventricular pressure (LVP) curves. Then, LVP signals were inputted into a BL-420F biological signal collection system (Taimeng Tech. Ltd., Chengdu, China) and the heat rate, LVP maximum rise or fall speed (±dp/dt max ), left ventricular systolic pressure (LVSP), and left ventricular end diastolic pressure (LVEDP) were recorded.
Determination of heart weight index and left ventricular weight index
After functional measurement was obtained, the heart was removed and washed at 4 C and weighed after being dried. The left ventricle was weighed and rat heart weight index (whole heart weight/body weight) and left ventricular weight index (left ventricular weight/body weight) were calculated. Next, the myocardial specimen of the left ventricle was cut into two parts; one part was stored at À80 C for reverse transcriptase polymerase chain reaction (RT-PCR) assay, and the other part was fixed with 10% formalin and then embedded in paraffin for spectroscopic analysis and detection of the protein expressions of TGF-b 1 , Smad 3 , and Smad 7 through immunohistochemistry.
Measurement of myocardial interstitial collagen volume fraction
After the paraffin sections were dewaxed, they were stained with Masson's dye and observed under a light microscope. Myocardial cells and collagen fibers were dyed in red and blue, respectively. Next, the sections were photographed and scanned to calculate the interstitial collagen volume fraction (CVF) using an image analyzer (CVF ¼ collagen area/total area). In each section, the measurements were performed by choosing five high-power fields and then obtaining mean area values.
Immunohistochemistry assay
Myocardial tissue sections were dewaxed with xylene and ethanol, and antigen repair and serum blocking were performed. The primary antibody (at 4 C overnight) and secondary antibodies (rabbit antirat TGF-b 1 , Smad 3 , and Smad 7 antibodies; Beijing Bioss Ltd., Beijing, China) were added, and 3,3 0 -diaminobenzidine (DAB) coloration, hematoxylin redyeing, dehydration, and mounting were performed in order. A brown-yellow coloration represented a positive expression under the microscope. Ten high-power fields were chosen in sections from each group to be observed randomly and analyzed using a CIAS-1000 cell image analyzer (Beijing Daheng Image Vision, Ltd., Beijing, China).
RT-PCR
Myocardial tissue, which was stored at À80 C, was taken and 1 mL of Trizol solution was added to extract total RNA. RT 0 . PCR conditions were as follows: initial melting at 94 C for 5 minutes followed by 33 cycles of denaturation at 94 C for 30 seconds, annealing at an appropriate temperature for 30 seconds, and extension at 72 C for 30 seconds. The PCR was then given a final extension step of 72 C for 7 minutes. The transcripts were checked subsequently using 2% agarose gel electrophoresis, and integrated optical density was presented by the ratio of TGFb 1 , Smad 3 , Smad 7 , and b-actin.
Statistical analysis
Statistical analysis was performed using the SPSS 13.0 software (SPSS, Inc., Chicago, IL, USA). Measured data were presented as means ± standard deviation. The Q-test and one-way analysis of variance were used to compare the data between two groups; p < 0.05 denoted a significant statistical difference. SPSS 13.0 statistical software (SPSS, Inc.) was used for data processing. The data were expressed as (x ± s). The multigroup comparison was performed using analysis of variance, and the intergroup comparison was performed using the standard pairwise q test (StudenteNewmaneKeuls method). A p value < 0.05 was considered a statistically significant difference.
Results
General condition
After injection of STZ, the rats presented typical symptoms of diabetes (diuresis, polydipsia, and polyphagia) and their weight increased slowly along with gradually increasing listlessness; meanwhile, their hair became thin and lackluster. At the end of the study, two rats died due to infection in the diabetic group and one rat was dead in the Tongxinluo group. Therefore, 25 rats survived.
Effect of Tongxinluo on heart function
Heart function was judged by the measurement of LVP (±dp/ dt max ). We also measured LVSP and LVEDP, which reflected systole and abnormal diastolic function, respectively. Compared with the control group, LVSP and ±dp/dt max were lower, but LVEDP was higher in the diabetic group. Furthermore, LVSP and ±dp/dt max were clearly higher in the Tongxinluo group than in the diabetic group. However, LVEDP was significantly lower in the Tongxinluo group than in the diabetic group (Table 1) .
Effect of Tongxinluo on blood glucose level, heart weight index, and left ventricular weight index
At the end of 12 weeks, the blood glucose level was higher in the diabetic group than in the control group. The heart weight index and left ventricular weight index were also clearly higher in the diabetic group. Furthermore, compared with the diabetic group, there was no obvious difference in blood glucose level in the Tongxinluo group. The heart weight index and left ventricular weight index were significantly reduced, but were still higher than those in the control group (Table 2) .
Measurement of myocardial interstitial CVF
Under the light microscope, myocardial cells were seen surrounded by only a few collagen fibers that were blue, thin, and well distributed in the control group. However, many large collagen fibers that were poorly aligned and unevenly distributed were observed in the diabetic group. In addition, compared with the diabetic group, the number of blue collagen fibers was lower in the Tongxinluo group. CVF was determined by image analysis, and when compared with the control group, it was significantly higher in the diabetic group. Compared with the diabetic group, CVF was clearly reduced in the Tongxinluo group, but was still higher than that in the control group (Table 2) .
Protein expressions of TGF-b 1 , Smad 3 , and Smad 7
TGF-b 1 and Smad 3 were brownish-yellow particles located in the myocardial cytoplasm, periplasm, and surrounding Table 1 Comparisons of heart function in three groups (x ± s). Compared with the control group, the mRNA expressions of TGF-b 1 and Smad 3 were higher, but the expression of Smad 7 was significantly lower in the diabetic group. Furthermore, compared with the diabetic group, the mRNA expressions of TGF-b 1 and Smad 3 were clearly lower, but the expression of Smad 7 was significantly higher in the Tongxinluo group (Table 4 , Fig. 2 ).
Group
Discussion
DCM is a chronic complication of diabetes. In diabetes mellitus, alterations in cardiac function in the absence of ischemic heart disease, hypertension, or other cardiac pathologies are termed DCM. 12 Recent studies have found that intermyocardial collagen deposition and myocardial fibrosis are important features of DCM. Fibrosis is characterized by ECM accumulation and often by a change in the quality of the ECM, such as Type I and Type III collagen. 13 Myocardial fibrosis is a major pathological characteristic in the Table 2 Comparisons of blood sugar, heart weight index, left ventricular weight index, and CVF in three groups (x ± s). The pairwise q test showed that there were significant differences in blood glucose, heart weight index, left ventricular mass index, and CVF among the three groups, p < 0.05. CVF ¼ collagen volume fraction. Fig. 1 . In the control group, the protein expressions of TGF-b1 and Smad 3 were presented as weakly positive, and the protein expression of Smad 7 was strongly positive. In the diabetic group, the protein expressions of TGF-b1 and Smad 3 were strongly positive, but the expression of Smad 7 was reduced significantly. In the Tongxinluo group, protein expressions of TGF-b1 and Smad 3 obviously reduced, but the expression of Smad 7 increased significantly compared with that in the diabetic group. TGF-b 1 ¼ transforming growth factor beta 1.
development and occurrence of DCM. It causes a significant increase in ECM, and diastolic dysfunction is induced by diffused myocardial fibrosis. 14 Diastolic dysfunction represents the earliest preclinical manifestation of DCM. 15 This is followed by the development of systolic dysfunction and a clear reduction of the left ventricular ejection fraction, 16, 17 which can easily cause arrhythmia and heart failure, even sudden death. 18 TGF-b 1 is a polypeptide member of the TGFb superfamily of cytokines. A high expression of TGF-b 1 promotes the occurrence of fibrosis in myocardial tissue, by increasing the synthesis and secretion of ECM and the production of collagen and matrix proteins. TGF-b 1 reduces the degradation of ECM, which leads to myocardial ECM accumulation, ultimately leading to myocardial fibrosis. 19 A previous study showed that TGF-b 1 was overexpressed and the synthesis of Type I and Type III collagen increased in an animal model of ventricular remodeling. 20 TGF-b1 binds to specific receptors on the cell surface to exert its biological effects; Type I (TGF-b1 receptor I, TGF-b1RI) and Type II (TGF-b1RII) receptors have high affinities and signal transduction functions.
Smad protein is a frequently studied substrate. It is the only substrate transducing the signal downstream of the TGF-b1RI activating enzyme. Smads are intracellular signal transduction proteins of the TGF-b1 pathway and are involved in the Table 4 Comparisons of the mRNA expressions of TGF-b 1 , Smad 3 , and Smad 7 in three groups (x ± s). The pairwise q test showed that there existed significant differences in the expressions of TGF-b 1 , Smad 3 , and Smad 7 mRNA among the three groups, p < 0.05. TGF-b 1 ¼ transforming growth factor beta 1. The pairwise q test showed that there existed significant differences between two indicators among the three groups, p < 0.05. TGF-b 1 ¼ transforming growth factor beta 1. Some studies have shown that Tongxinluo could regulate the TGF-b1/Smad signaling pathway, thereby improving the functions of the target organs. Wang et al 23 applied Tongxinluo while treating diabetic nephropathy, and used technologies such as RT-PCR, cell transfection, in situ hybridization, and laser confocal microscopy. It was found that Tongxinluo could block the miR-21-regulated TGF-b 1 /Smad 3 pathway and increase the expression of Smad 7 , thus improving renal structures and functions, and playing a protective role in diabetic nephropathy. Our study showed that the protein and mRNA expression levels of TGF-b 1 were clearly higher in the diabetic and Tongxinluo groups than in the control group. However, compared with the diabetic group, the protein and mRNA expression levels of TGF-b 1 were lower in the Tongxinluo group, which suggested that Tongxinluo could reduce the expression of TGF-b 1 in rats with DCM and alleviate the occurrence and development of DCM.
This study also found that the protein and mRNA expressions of Smad 3 were higher in the myocardial tissue of diabetic rats. However, the expression of Smad 7 decreased. In the Tongxinluo group, the expression of Smad 7 was significantly higher, but Smad 3 expression was lower. This implies that Smad 3 might be involved in the occurrence and development of DCM and that Smad 7 plays a protective role in DCM through the Smad 7 /TGF-b 1 signaling pathway. The results of this study further showed that Tongxinluo could prevent and treat myocardial fibrosis in diabetic rats. The mechanism of action of Tongxinluo could be through its effect on the intracellular signal transduction of TGF-b 1 , wherein it downregulates the expressions of TGF-b 1 and Smad 3 , and upregulates the expression of Smad 7 to relieve myocardial fibrosis and improve heart function in diabetic rats. These results indicate that Tongxinluo has a protective effect on the myocardial tissue of diabetic rats. However, Tongxinluo is composed of many herbs and insects, including Panax ginseng, leech, scorpion, Radix paeoniaerubra, periostracum cicadae, ground beetle, centipede, sandalwood, rosewood, heartwood, frankincense, semen Ziziphi Spinosae, and borneol; whether the protective effect on myocardial tissue observed in this study is imparted by a single ingredient or multiple compounds is still not clear. Therefore, further studies are needed to determine the exact mechanism.
